Perfect Medical Health Management Limited

Sümbol: 1830.HK

HKSE

3.12

HKD

Turuhind täna

9.2134
P/E suhe
0.0000
PEG suhe
3.92B
MRK Cap
0.02%
DIV tootlus

Perfect Medical Health Management Limited (1830-HK) Finantsaruanded

Q: Mis on ettevõtte kasumimarginaal?

Ettevõtte kasumimarginaal on .

Download

Aastane Quarterly

Lineaarne Log

Diagrammil näete Perfect Medical Health Management Limited (1830.HK) vaikimisi numbreid dünaamikates. Companys revenue näitab keskmist NaN M, mis on NaN % gowth. Kogu perioodi keskmine brutokasum on NaN M, mis on NaN %. Keskmine brutokasumi suhtarv on NaN %. Ettevõtte eelmise aasta tulemuse puhaskasv on NaN %, mis on võrdne NaN % % keskmiselt kogu ettevõtte ajaloo jooksul.,

Aastane Quarterly

10Y 20Y 30Y 40Y

Bilanss

Sukeldudes Perfect Medical Health Management Limited fiskaalkäiguteele, täheldame keskmist varade kasvu. See määr on huvitaval kombel , mis kajastab nii ettevõtte kõrg- kui ka madalseisusid. Kui võrrelda kvartalite lõikes, siis kohandub see näitaja . Kui vaadata tagasi möödunud aastale, siis on varade kogumuutus NaN. Aktsionäride väärtus, mida näitab aktsionäride kogu omakapital, on hinnatud NaN aruandlusvaluutas. Selle aspekti aastane muutus on NaN%.

common:word.in-mln USD Growth	2021	2019	2017	2015	2013	2011
balance-sheet.row.cash-and-short-term-investments	656.8	454.4	532.9	671.1	457.9	419.9	315.9	282.2	409.7	214	128.2	205.7	74.2
balance-sheet.row.short-term-investments	210.2	0.2	34.3	104.6	84	85.5	16.9	47.3	22.5	35.1	18.7	0	0
balance-sheet.row.net-receivables	50.3	16	79.5	76.1	153.6	165.9	63.5	57.2	61.1	36	110.9	28.1	66.5
balance-sheet.row.inventory	8.9	5.9	2.8	1.8	2.7	2	1.3	4.5	1.7	3	2.6	0.6	1.1
balance-sheet.row.other-current-assets	36.2	31.9	38.6	38.8	59.3	86.7	77.7	53.3	38	43.7	58.1	81.5	46.8
balance-sheet.row.total-current-assets	752.3	508.1	653.8	787.9	638.1	639.5	458.3	397.2	510.5	296.8	299.8	315.9	188.5
balance-sheet.row.property-plant-equipment-net	409.9	553.3	435.6	391	108.5	138.4	184.8	229.2	198.5	62.6	52.4	39.6	32.4
balance-sheet.row.goodwill	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.intangible-assets	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.goodwill-and-intangible-assets	0	0	0	0	169.5	104.4	226.5	259.2	0	0	24.5	0	0
balance-sheet.row.long-term-investments	89	110.4	309.1	37.2	70.3	23	52.4	37.9	0	0	50.1	0	0
balance-sheet.row.tax-assets	8.5	56.5	53.9	52.2	9.3	11.1	10.7	7.9	7.1	6.9	9	9.8	12.9
balance-sheet.row.other-non-current-assets	36.6	52.9	28	31	-178.8	-138.4	-10.7	-7.9	-7.1	-6.9	-52.4	18.3	25.1
balance-sheet.row.total-non-current-assets	544	773.1	826.6	511.4	178.8	138.4	237.2	267.1	198.5	62.6	83.6	67.7	70.4
balance-sheet.row.other-assets	0	0	0	0	38.5	40.6	42.5	41.5	30.7	26.6	0	0	0
balance-sheet.row.total-assets	1296.3	1281.2	1480.4	1299.2	855.4	818.5	738	705.8	739.8	386	383.3	383.6	258.9
balance-sheet.row.account-payables	0.8	1.6	0.7	0.7	0.6	0.6	0.8	0.9	1.3	1.4	1.8	0.9	1.5
balance-sheet.row.short-term-debt	114.5	135.4	105.6	93.5	-116.3	-204.3	-173.3	-132.1	0	0	0	0	0
balance-sheet.row.tax-payables	85.6	89.7	45.5	58.6	70.2	31.5	27.7	23.9	20.3	16.1	15.9	8.2	14.8
balance-sheet.row.long-term-debt-total	125.9	175.7	156	158.5	0	0	0	0	0	0	0	0	0
Deferred Revenue Non Current	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.deferred-tax-liabilities-non-current	-	-	-	-	-	-	-	-	-	-	-	-	-
balance-sheet.row.other-current-liab	153.4	149.3	136.4	130.5	263.9	319.5	85.2	85.1	229.9	136.6	131.9	156.4	204.6
balance-sheet.row.total-non-current-liabilities	163.2	264	236	236.8	30.2	28.2	14.8	12.2	15.9	9.7	7.7	5.5	3.9
balance-sheet.row.other-liabilities	0	0	0	0	0	0	10.2	8.2	0	0	0	0	0
balance-sheet.row.capital-lease-obligations	125.9	175.7	156	158.5	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-liab	684	786.9	795.5	620.2	294.7	348.4	284.3	238.5	247.1	147.6	141.4	162.8	210
balance-sheet.row.preferred-stock	0	0	0	0	0	0	0	2.3	0	0	0	0	0
balance-sheet.row.common-stock	125.7	124	122.3	111.6	110.5	108.6	109.4	112.2	112.7	100	100	100	0
balance-sheet.row.retained-earnings	200.2	91.6	259.8	447.5	252.5	122.8	60.9	62.4	70.6	44.1	44.9	25.7	46.7
balance-sheet.row.accumulated-other-comprehensive-income-loss	-50	-50.5	-30.5	-8.8	16.1	24.3	12.5	-2.3	0	0	0	0	0
balance-sheet.row.other-total-stockholders-equity	336.5	329.2	333.3	128.7	181.6	214.5	270.9	295	309.4	94.2	97	95	2.1
balance-sheet.row.total-stockholders-equity	612.3	494.3	684.8	679	560.7	470.2	453.7	467.3	492.7	238.4	241.9	220.7	48.8
balance-sheet.row.total-liabilities-and-stockholders-equity	1296.3	1281.2	1480.4	1299.2	855.4	818.5	738	705.8	739.8	386	383.3	383.6	258.9
balance-sheet.row.minority-interest	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-equity	612.3	494.3	684.8	679	560.7	470.2	453.7	467.3	492.7	238.4	241.9	220.7	48.8
balance-sheet.row.total-liabilities-and-total-equity	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Investments	299.2	110.6	343.4	141.9	154.3	85.5	69.3	85.2	22.5	35.1	68.7	0	0
balance-sheet.row.total-debt	240.4	311.1	261.6	252	0	0	0	0	0	0	0	0	0
balance-sheet.row.net-debt	-206.3	-143.1	-237	-314.4	-338.7	-299.4	-299	-234.9	-387.3	-178.9	-109.5	-205.7	-74.2

Rahavoogude aruanne

Perfect Medical Health Management Limited finantsmaastikul on viimase perioodi jooksul toimunud märkimisväärne muutus vabas rahavoos, mis näitab NaN nihet. Ettevõte laiendas hiljuti oma aktsiakapitali, emiteerides NaN, mis tähistab NaN erinevust võrreldes eelmise aastaga. Ettevõtte investeerimistegevuse tulemusel kasutas ettevõte netosularaha, mis aruandlusvaluutas oli NaN. See on NaN nihkumine võrreldes eelmise aastaga. Samal perioodil registreeris ettevõte NaN, NaN, NaN, mis on olulised ettevõtte investeerimis-ja tagasimaksestrateegiate mõistmiseks. Ettevõtte finantseerimistegevuse tulemusel kasutas ettevõte netorahavahendeid NaN, kusjuures erinevus võrreldes eelmise aastaga oli NaN. Lisaks eraldas ettevõte NaN aktsionäridele dividendide maksmiseks. Samal ajal tegi ta muid finantsmanöövreid, millele viidatakse kui NaN, mis samuti mõjutasid oluliselt tema rahavooge sel perioodil. Need komponendid koos annavad tervikliku pildi ettevõtte finantsseisundist ja strateegilisest lähenemisest rahavoogude juhtimisele.

common:word.in-mln USD Growth	2021	2019	2017	2015	2013	2011
cash-flows.row.net-income	315.6	305.2	284.6	360.2	319	194.2	91.4	130	134.9	83	109.1	90.3	65.7
cash-flows.row.depreciation-and-amortization	223.6	219	171.3	154.8	70.4	79.9	86	79.8	45.8	28.1	23.7	18.1	16.5
cash-flows.row.deferred-income-tax	-460.8	-416.8	-343	-233.9	-14.6	98.6	-1	-2.4	0	0	0	0	0
cash-flows.row.stock-based-compensation	4.2	4.6	3.1	1	3.1	4.3	4.2	1.5	0	0	0	0	0
cash-flows.row.change-in-working-capital	9.7	-73.7	152.1	121.9	11.5	-102.9	-3.2	0.9	-23.8	-17	-60.2	-24.4	25.7
cash-flows.row.account-receivables	-23.7	63.2	-3.2	78.8	12.1	-102.1	-6.5	3.8	-25.1	-16.6	-10.2	0	0
cash-flows.row.inventory	-3	-3.1	-1	0.9	-0.6	-0.7	3.2	-2.8	1.3	-0.4	-2	0.5	0
cash-flows.row.account-payables	17.3	-34.3	6.8	-2.8	-2.9	6.4	-3.2	11.5	0	0	10.2	0	0
cash-flows.row.other-working-capital	19.1	-99.5	149.5	45.1	2.9	-6.4	3.2	-11.5	0	0	-48	-24.9	25.7
cash-flows.row.other-non-cash-items	468.3	478.4	337.7	241.4	64	-30.4	27.1	-20.5	90.3	-3.1	-22.8	-27.2	-14.3
cash-flows.row.net-cash-provided-by-operating-activities	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.investments-in-property-plant-an-equipment	-26.7	-144.6	-78.2	-96.4	-53.2	-37.7	-41.2	-109.7	-180.6	-36.4	-39.4	-23.3	-24.4
cash-flows.row.acquisitions-net	0.2	1.6	1.9	4	17.5	5.8	1	3.2	0	-19.7	0.2	0	0
cash-flows.row.purchases-of-investments	-210	-233.5	-720.6	-103.8	-73.5	-133.9	-51.2	-72.4	0	-25.2	-61.5	-73.1	-173
cash-flows.row.sales-maturities-of-investments	16.3	385.4	496.9	121.9	16.2	96.9	72.7	69.1	0	44.9	50.1	0	0
cash-flows.row.other-investing-activites	-2.3	-0.9	-0.8	-1	-1.7	-1.1	-3.9	-14.9	22.2	82.2	-38	51.1	128.3
cash-flows.row.net-cash-used-for-investing-activites	-222.5	8.1	-300.8	-75.2	-94.7	-70	-22.6	-193.7	-158.4	65.4	-88.5	-45.3	-69.1
cash-flows.row.debt-repayment	-135.7	-137.7	-109.5	-87.8	0	-2.4	0	0	-229.7	0	0	0	0
cash-flows.row.common-stock-issued	15	15	15	30	20	15	0	0	240.9	0	0	0	0
cash-flows.row.common-stock-repurchased	-10	-21.7	-4.5	-42	0	-17.4	-21.5	-6.2	-11.2	0	0	0	0
cash-flows.row.dividends-paid	-191.8	-405.5	-282.3	-218.8	-271.9	-132.3	-92.8	-138.2	-108.5	-87	-58	-73.4	0
cash-flows.row.other-financing-activites	-12.5	-16.1	-13.1	-11.9	-55.3	-51.5	0	0	0	0	0	191.7	0
cash-flows.row.net-cash-used-provided-by-financing-activities	-335	-566	-394.4	-330.5	-307.1	-188.7	-114.3	-144.4	121.2	-87	-58	118.3	0
cash-flows.row.effect-of-forex-changes-on-cash	-9.9	-3.2	21	-15.9	-12.3	15.5	-4.5	-6	-1.8	0	0.4	1.7	1.5
cash-flows.row.net-change-in-cash	-7.5	-44.4	-67.9	223.8	39.3	0.4	64.1	-152.3	208.4	69.4	-96.2	131.5	26
cash-flows.row.cash-at-end-of-period	446.6	454.2	498.6	566.5	338.7	299.4	299	234.9	387.3	178.9	109.5	205.7	74.2
cash-flows.row.cash-at-beginning-of-period	454.2	498.6	566.5	342.7	299.4	299	234.9	387.3	178.9	109.5	205.7	74.2	48.2
cash-flows.row.operating-cash-flow	560.6	516.7	605.9	645.4	453.4	243.6	205.5	191.8	247.3	91	49.9	56.8	93.5
cash-flows.row.capital-expenditure	-26.7	-144.6	-78.2	-96.4	-53.2	-37.7	-41.2	-109.7	-180.6	-36.4	-39.4	-23.3	-24.4
cash-flows.row.free-cash-flow	533.8	372.2	527.7	549	400.2	205.9	164.3	82.1	66.7	54.6	10.5	33.5	69.2

Kasumiaruande rida

Perfect Medical Health Management Limited tulud muutusid võrreldes eelmise perioodiga NaN%. 1830.HK brutokasum on teatatud NaN. Ettevõtte tegevuskulud on NaN, mille muutus võrreldes eelmise aastaga on NaN%. Kulud amortisatsioonikulud on NaN, mis on NaN% muutus võrreldes eelmise aruandeperioodiga. Tegevuskulud on teatatud NaN, mis näitab NaN% muutust võrreldes eelmise aastaga. Müügi- ja turunduskulud on NaN, mis on NaN% muutus võrreldes eelmise aastaga. Hiljutistel numbritel põhinev EBITDA on NaN, mis tähendab NaN% kasvu võrreldes eelmise aastaga. Tegevustulu on NaN, mis näitab NaN% muutust võrreldes eelmise aastaga. Puhaskasumi muutus on NaN%. Eelmise aasta puhaskasum oli NaN.

common:word.in-mln USD Growth	2021	2019	2017	2015	2013	2011
income-statement-row.row.total-revenue	1389.3	1350	1089.8	1241	1197	906.3	757	879.1	728.7	470.2	443	381.2	309
income-statement-row.row.cost-of-revenue	726.7	660	536.3	525.9	354.3	301.7	263.8	282.8	243.3	141.4	8.8	0	0
income-statement-row.row.gross-profit	662.6	689.9	553.4	715	842.7	604.6	493.2	596.3	485.4	328.8	434.3	381.2	309
income-statement-row.row.gross-profit-ratio	0	0	0	0	0	0	0	0	0	0	0	0	0
income-statement-row.row.research-development	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.selling-general-administrative	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.selling-and-marketing-expenses	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.other-expenses	-0.5	-1.5	-0.4	-1.5	-1.5	-81.1	2	0.3	0	0	0	0	0
income-statement-row.row.operating-expenses	293.8	306.1	250.6	261.2	444.2	353.9	381.9	443	315.4	222.2	314.8	293.3	243.5
income-statement-row.row.cost-and-expenses	1020.5	966.2	786.9	787.2	798.5	655.6	645.7	725.8	558.7	363.6	323.6	293.3	243.5
income-statement-row.row.interest-income	7.9	1.7	5.4	6.3	5.5	4.1	5.8	7.4	6.8	3.2	3.6	2.5	0.2
income-statement-row.row.interest-expense	12.5	16.1	13.1	11.9	0	0	0	0	0	0	0	0	0
income-statement-row.row.selling-and-marketing-expenses	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.total-other-income-expensenet	22.6	-5.6	55.3	-3.2	8.2	18.5	-0.6	-0.7	5.7	10.9	4.3	2.5	0.2
income-statement-row.row.ebitda-ratio-caps	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.other-operating-expenses	-0.5	-1.5	-0.4	-1.5	-1.5	-81.1	2	0.3	0	0	0	0	0
income-statement-row.row.total-operating-expenses	22.6	-5.6	55.3	-3.2	8.2	18.5	-0.6	-0.7	5.7	10.9	4.3	2.5	0.2
income-statement-row.row.interest-expense	12.5	16.1	13.1	11.9	0	0	0	0	0	0	0	0	0
income-statement-row.row.depreciation-and-amortization	223.6	219	171.3	154.8	70.4	79.9	86	79.8	45.8	28.1	23.7	18.1	16.5
income-statement-row.row.ebitda-caps	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.operating-income	368.8	383.8	302.9	453.8	395.9	236.3	117.7	161.4	171	98.9	105.5	87.8	65.5
income-statement-row.row.income-before-tax	391.5	378.2	358.2	450.6	404.1	254.8	117.1	160.7	176.7	109.8	109.1	90.3	65.7
income-statement-row.row.income-tax-expense	75.8	72.9	73.5	90.4	85	60.6	25.8	30.7	41.8	26.8	31.1	21.6	15.4
income-statement-row.row.net-income	315.6	305.2	284.6	360.2	319	194.2	91.4	130	134.9	83	78	68.7	50.3